Quality

The focus of quality improvement in healthcare is to bolster performance and processes related to diagnostic and therapeutic procedures. Leaders in this space also ensure the proper selection of imaging exams and procedures, and monitor the safety of services, among other duties. Reimbursement programs such as the Merit-based Incentive Payment System (MIPS) utilize financial incentives to improve quality. This also includes setting and maintaining care quality initiatives, such as the requirements set by the Joint Commission.

Thumbnail

CMS suspends data collection of sepsis and septic shock data from hospitals

In a letter sent to hospitals participating in the Hospital Inpatient Quality Reporting (IQR) Program, the Centers for Medicare & Medicaid Services (CMS) says it is suspending data collection for the Severe Sepsis and Septic Shock: Management Bundle measure (NQF #0500) until further notice.

Thumbnail

Massachusetts stats show better safety reporting can make problem seem worse

Quality and safety improvement begins with accurate measurement of the problem, including recording every incident regardless of whether a patient was seriously harmed or not. However, recent data from Massachussetts shows that better measurement can create a drastic increase in the rate of adverse events — in this case an attention grabing jump of 70 percent in one year.

Thumbnail

Tennessee hospitals’ surgical quality collaboration saved 533 lives, $75 million

New results from the 22-hospital Tennessee Surgical Quality Collaborative (TSQC) indicate that in just three years, the 10 original hospitals that formed the collaborative were able to reduce surgical complications by 19.7 percent and 30-day mortality by 31.5 percent. The hospitals’ researchers say this equates to at least 533 lives saved and $75.2 million in reduced costs.

Thumbnail

NQF to study sociodemographic risk adjustment of hospital performance measures

The National Quality Forum’s (NQF) Board of Directors has approved a robust trial to measure the potential impact and implications of creating a risk factor that would adjust relevant hospital payment quality measures to take into account the challenges presented in achieving the same outcomes for patients with low socioeconomic and/or minority status as for those who are more well off economically and not minorities.

Thumbnail

Leapfrog hospital survey reveals wide variation in high-risk procedure survival rates and hospital-acquired injury and infection rates

The annual survey of hospital safety and quality by the non-profit Leapfrog Group and Castlight Health finds improvement and increased participation by hospitals, but also reflects a “surprisingly high variance” in high-risk procedure survival rates and hospital-acquired injury and infection rates.

Thumbnail

AHA/HRET hospital engagement network says it saved $1.3 billion over 2 years

One of the nation’s largest hospital engagement networks (HENs) is the more than 1,500-member HEN operated by the American Hospital Association (AHA) and its Health Research & Educational Trust (HRET). In its first 28 months of operation, it says it saved more than $1.3 billion by reducing the incidence of preventable harm, readmissions and infections, as well as the incidence of early elective deliveries.

Thumbnail

VCU Medical Center wins AHA-McKesson national Quest for Quality prize

The Virginia Commonwealth University (VCU) Medical Center in Richmond, Virginia, is this year’s American Hospital Association (AHA)-McKesson Quest for Quality Prize winner for its “impressive culture of safety and focus on effectiveness.”

Thumbnail

U.S. News & World Report releases hospital rankings

The annual ranking of U.S. hospitals by the news magazine U.S. News & World Report has long stirred controversy, particularly by the heavy weight it gives to hospital reputation as measured by the votes of just a few hundred American Medical Association member physicians. However, its influence in hospital marketing is undeniable.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.